Post-COVID 19
Hyperbaric oxygen therapy (HBOT) can induce neuroplasticity and improve cognitive, psychiatric, fatigue, sleep and pain symptoms of patients suffering from post-COVID-19 condition. HBOT’s beneficial effect may be attributed to increased brain perfusion and neuroplasticity in regions associated with cognitive and emotional roles.
Data and Studies from The Sagol Center
-
The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial
Scientific Reports volume 13, Article number: 9473. 10 June 2023
-
Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: A randomized, sham-controlled trial
NeuroImage: Clinical, Volume 36, 2022, 103218
-
Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial
Scientific Reports volume 12, Article number: 11252 (2022)